The term booster has become “pervasive,” and will be difficult for people to stop using, CDC vaccine advisory committee member Keipp Talbot, MD, told CBS.
“To clarify, these vaccines would not be considered ‘boosters’ per se,” an FDA spokesperson told the news outlet. “These vaccines, as previously announced, would be updated with a new formulation for the 2023-2024 fall and winter seasons.”
The terminology is changing to match how public health agencies are aiming to prevent the virus the same way they do the flu.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
